Article citationsMore>>

Zhou, C., Wu, Y.L., Chen, G., Feng, J., Liu, X.Q., Wang, C., Zhang, S., Wang, J., Zhou, S., Ren, S., Lu, S., Zhang, L., Hu, C., Hu, C., Luo, Y., Chen, L., Ye, M., Huang, J., Zhi, X., Zhang, Y., Xiu, Q., Ma, J., Zhang, L. and You, C. (2011) Erlotinib versus Chemotherapy as Firstline Treatment for Patients with Advanced EGFR Mutation Positive Non Small Cell Lung Cancer (OPTIMAL, CTONG0802): A Multicentre, Openlabel, Randomised, Phase 3 Study. The Lancet Oncology, 12, 735-742.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
Free SCIRP Newsletters
Copyright © 2006-2021 Scientific Research Publishing Inc. All Rights Reserved.